Sally Batham
HCG Cancer Centre(IN)
Publications by Year
Research Areas
COVID-19 Clinical Research Studies, Influenza Virus Research Studies, Respiratory viral infections research, SARS-CoV-2 and COVID-19 Research, Pneumonia and Respiratory Infections
Most-Cited Works
- → Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD(2010)171 cited
- → Immunogenicity and safety of a two-dose schedule of whole-virion and AS03A-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial(2010)94 cited
- → Adults hospitalised with acute respiratory illness rarely have detectable bacteria in the absence of COPD or pneumonia; viral infection predominates in a large prospective UK sample(2014)79 cited
- → C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD(2014)70 cited
- → Randomised controlled trial and health economic evaluation of the impact of diagnostic testing for influenza, respiratory syncytial virus and Streptococcus pneumoniae infection on the management of acute admissions in the elderly and high-risk 18- to 64-year-olds(2014)52 cited
- → Hiding large amount of data using a new approach of video steganography(2013)32 cited
- → Safety and immunogenicity of whole-virus, alum-adjuvanted whole-virus, virosomal, and whole-virus intradermal influenza A/H9N2 vaccine formulations(2009)31 cited
- → Viral load is strongly associated with length of stay in adults hospitalised with viral acute respiratory illness(2016)25 cited
- → A randomised, partially observer blind, multicentre, head-to-head comparison of a two-dose regimen of Baxter and GlaxoSmithKline H1N1 pandemic vaccines, administered 21 days apart(2010)11 cited
- → Immunogenicity and safety of a two-dose schedule of whole-virion and AS03(A)-adjuvanted 2009 influenza A (H1N1) vaccines: a randomised, multicentre, age-stratified, head-to-head trial(2011)7 cited